211 related articles for article (PubMed ID: 34465286)
1. Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study.
Chen YH; Chen CH; Chien CY; Su YY; Luo SD; Li SH
BMC Cancer; 2021 Sep; 21(1):979. PubMed ID: 34465286
[TBL] [Abstract][Full Text] [Related]
2. JMJD3 suppresses tumor progression in oral tongue squamous cell carcinoma patients receiving surgical resection.
Chen YH; Chen CH; Chien CY; Su YY; Luo SD; Li SH
PeerJ; 2022; 10():e13759. PubMed ID: 35855897
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of UTX expression in patients with clear cell renal cell carcinoma.
Wang J; Liu L; Xi W; Long Q; Wang Y; Bai Q; Xia Y; Xu J; Guo J
Urol Oncol; 2016 Aug; 34(8):338.e19-27. PubMed ID: 27106782
[TBL] [Abstract][Full Text] [Related]
4. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
Liu L; Wang X; Ge W
Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer.
Li H; Zhang J; Chen SW; Liu LL; Li L; Gao F; Zhuang SM; Wang LP; Li Y; Song M
J Transl Med; 2015 Jun; 13():198. PubMed ID: 26094024
[TBL] [Abstract][Full Text] [Related]
6. Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.
Heikkinen I; Almangush A; Hagström J; Bello IO; Kauppila JH; Mäkinen LK; Haglund C; Nieminen P; Salo T; Leivo I
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3905-3911. PubMed ID: 27091335
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
[TBL] [Abstract][Full Text] [Related]
8. Histone demethylase UTX is a therapeutic target for diabetic kidney disease.
Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K
J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma.
Li SH; Lu HI; Huang WT; Tien WY; Lan YC; Lin WC; Tsai HT; Chen CH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351209
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma.
Wen H; Chen Y; Hu Z; Mo Q; Tang J; Sun C
Oncol Rep; 2014 Jan; 31(1):169-74. PubMed ID: 24252932
[TBL] [Abstract][Full Text] [Related]
11. Loss of p21WAF1/CIP1 expression in invasive fronts of oral tongue squamous cell carcinomas is correlated with tumor progression and poor prognosis.
Goto M; Tsukamoto T; Inada K; Mizoshita T; Ogawa T; Terada A; Hyodo I; Shimozato K; Hasegawa Y; Tatematsu M
Oncol Rep; 2005 Oct; 14(4):837-46. PubMed ID: 16142340
[TBL] [Abstract][Full Text] [Related]
12. Nox4 Overexpression as a Poor Prognostic Factor in Patients with Oral Tongue Squamous Cell Carcinoma Receiving Surgical Resection.
Chen YH; Chien CY; Fang FM; Huang TL; Su YY; Luo SD; Huang CC; Lin WC; Li SH
J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30513726
[TBL] [Abstract][Full Text] [Related]
13. FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.
Imayama N; Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Seki S; Fujita S; Ikeda T; Umeda M
Pathol Oncol Res; 2015 Jul; 21(3):783-91. PubMed ID: 25573594
[TBL] [Abstract][Full Text] [Related]
14. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
Sengüven Toközlü B; Sapkota D; Vallenari EM; Schreurs O; Søland TM
Eur J Oral Sci; 2023 Apr; 131(2):e12925. PubMed ID: 36790139
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
[TBL] [Abstract][Full Text] [Related]
16. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases.
Rodrigues PC; Miguel MC; Bagordakis E; Fonseca FP; de Aquino SN; Santos-Silva AR; Lopes MA; Graner E; Salo T; Kowalski LP; Coletta RD
Int J Oral Maxillofac Surg; 2014 Jul; 43(7):795-801. PubMed ID: 24583139
[TBL] [Abstract][Full Text] [Related]
18. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.
Yuan C; Li Z; Qi B; Zhang W; Cheng J; Wang Y
J Oral Pathol Med; 2015 Feb; 44(2):159-65. PubMed ID: 25040359
[TBL] [Abstract][Full Text] [Related]
19. FGF-2 and FGFR-1 might be independent prognostic factors in oral tongue squamous cell carcinoma.
Mariz BALA; Soares CD; de Carvalho MGF; Jorge-Júnior J
Histopathology; 2019 Jan; 74(2):311-320. PubMed ID: 30129658
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.
Kauppila JH; Mattila AE; Karttunen TJ; Salo T
Br J Cancer; 2013 Feb; 108(3):638-43. PubMed ID: 23287987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
